tirzepatide pipeline Tirzepatide: First Approval | Drugs GLP-1 Pipeline graphic : r/Zepbound
Description
behavior modification strategies were recommended as needed

By disclosing risks, confirming contraindication screening, and obtaining witnessed acknowledgment, your clinic protects patients and practitioners while establishing transparent communication

The same class as Mounjaro and Zepbound

Nat Rev Endocrinol

The American Diabetes Association (ADA) guidelines recognize GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who require additional glucose-lowering therapy beyond metformin, particularly those with established cardiovascular disease or chronic kidney disease, with preference given to agents with proven cardiovascular benefit

There were a few minor side effects early on, but they faded quickly